For over 40 years, you’ve relied on more than our legacy, you’ve relied on our commitment to you.
Service
Quality
Advancement
Trust
Nexpring Health stands with you at every critical moment
Being a true partner means more than offering you high-quality products, it means delivering what you need, when you need it. We anticipate your challenges, we solve your problems with responsive, hands-on support. Because your success is what drives us every day.
ART leaders making a difference for clinics all over the world
Nexpring Health has every possibility of becoming THE go to choice for professionals in the field of assisted reproduction health care. The best of the best are coming together with unparalleled commitment to provide the highest quality products and services. It has always been a true blessing to be of service for professionals in the quest of helping patients grow a family and now we commit with great enthusiasm to the future of the field, moving forward with Nexpring Health!
Michael Magee Product Specialist – Americas
With years of experience as a clinical embryologist, I am deeply excited about the innovative solutions Nexpring Health brings to transform the daily reality of ART professionals worldwide. By upholding service and quality as our top priorities, we pave the way for groundbreaking opportunities in research, development, and advancing the field for future generations.
Donna Kinzer Senior Manager of Clinical Education, North and South America
Throughout my 18-year career as a Regional Manager for MEA, I’ve found joy in organizing workshops on embryo culture systems, collaborating with embryologists to share best practices. Learning from colleagues and customers continues to inspire our growth and transform patients’ lives.
Essam Moussa Assella MEA Regional Manager
Because the art of success is not achieved by one individual alone.
Tammy Frederickson OEM Procurement & Kitting Mgt
Here from the beginning, here for tomorrow
For over 40 years, our heritage is built on the foundation of trust, embedded in everything we do. We’re with clinicians, embryologists and fertility clinics at every critical moment, providing unwavering support, ensuring you have a partner you can rely on when it matters most.
1978
First IVF baby Louise Brown born in Oldham, UK
1980
Embryo transfer catheter
1986
Double-lumen ovum collection needle
1987
First commercially available IVF medium, HTF
1989
IVOS
1992
First baby born from ICSI
1994
First commercially available inter-cytoplasmic sperm injection (ICSI) pipettes
1997
SCA
1998
EchoTip embryo transfer catheter
2001
Embryo transfer catheter #1 globally
2002
First Laser ZILOS-tk
2005
Gynemed Media
2006
First commercially available vitrification products
2012
First uninterrupted culture medium
2014
1000 CASA worldwide
2015
FreyGren
2016
Javica
2017
Tulip ET catheters
2018
ZANDAIR™
2019
SCA SCOPE
2019
LYKOS® DTS
2020
BT37 Mark II
2025
Over 40 years of trust, countless lives changed, and one unwavering commitment
Every embryo, every procedure, every cycle, every day
From pre-IVF diagnosis to embryo transfer and beyond, we cover the entire fertility journey of care.
Consumables
Single-use laboratory essentials you can count on everyday to support precise and sterile IVF procedures.
A true partner delivers what you need, when you need it. We anticipate challenges, solve problems, and provide responsive, hands-on support at every critical moment.
Confident, experienced leaders driving the future of the ART industry.
Wil Boren
Chief Executive Officer
Wil Boren has spent his entire career in the medical device industry. Before joining Nexpring Health, Wil was the CEO of Paragon Medical, a contract design and manufacturing organization. Paragon Medical was owned by American Securities, and Wil led the sale of the company to AMETEK in the fall of 2023. Prior to joining Paragon, he served as the President of Advanced Surgery, a division of Baxter International, for five years. Before joining Baxter, Wil spent nearly two decades in the orthopedics sector, serving in various senior leadership roles at Biomet Orthopedics until the company’s sale to Zimmer in the summer of 2015. Wil earned his Bachelor of Science in Environmental Affairs from Indiana University and holds a fellowship from the Wharton School of Business.
Jimmy DeStephens
Chief Operating Officer / Chief Financial Officer
Jimmy DeStephens brings over 20 years of experience in finance, operations, and business development to Nexpring, focusing on the future of Assisted Reproductive Technologie (ART). Previously, he served as General Manager of the Global Wound Closure business at Corza Medical, where he implemented innovative go-to-market strategies and secured significant investments across the U.S. and Europe. His leadership journey also includes pivotal roles at Baxter Healthcare, Acelity, Medtronic, Covidien, and Tyco.
